(Q35683333)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003189%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003189%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

main subject

Guillain–Barré syndrome

0 references

author

Nina M van Sorge

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003189%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Marc D Jansen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003189%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Leonard H van den Berg

4

object named as

van den Berg LH

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003189%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

van der Pol WL

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003189%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003189%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003189%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003189%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003189%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

61-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003189%20AND%20SRC:MED&resulttype=core&format=json

Gangliosides: structure, isolation, and analysis

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Designation and schematic structure of gangliosides and allied glycosphingolipids

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Localization of major gangliosides in the PNS: implications for immune neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Ganglioside function in calcium homeostasis and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Pathogenesis of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Neonatal Guillain-Barré syndrome: blocking antibodies transmitted from mother to child.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Ganglioside reactive antibodies in the neuropathy associated with celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Antibodies to ganglioside GM1 in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Peripheral neuropathies and anti-glycolipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Presence and isotype of anti-ganglioside antibodies in healthy persons, motor neuron disease, peripheral neuropathy, and other diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Anti-GM1 antibodies can block neuronal voltage-gated sodium channels

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Features of the Guillain-Barré syndrome in mice following intraperitoneal injection of patient serum

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

The expression of CD59 in experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

IgG receptor polymorphisms: risk factors for disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Anti–GM1 IgG antibodies induce leukocyte effector functions via Fcγ receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

High affinity as a disease determinant factor in anti-GM(1) antibodies: comparative characterization of experimentally induced vs. disease-associated antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Anti-GM1 ganglioside IgM-antibodies present in human plasma: affinity and biological activity changes in a patient with neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

The origin of anti-GM1 antibodies in neuropathies: the "binding site drift" hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Clinical and epidemiologic features of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

HLA and T-cell receptor gene polymorphisms in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Presentation of the same glycolipid by different CD1 molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

1 reference

7 January 2021

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Expansion of human gammadelta T cells after in vitro stimulation with Campylobacter jejuni

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

Anti-GQ1b IgG antibody syndrome: clinical and immunological range

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900089-2

7 January 2021

10.1016/S1568-9972(03)00089-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003189%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference